![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Glajzer, Jacek; Castillo-Tong, Dan Cacsire; Richter, Rolf; Vergote, Ignace; Kulbe, Hagen; Vanderstichele, Adriaan; Ruscito, Ilary; Trillsch, Fabian; Mustea, Alexander; Kreuzinger, Caroline; Gourley, Charlie; Gabra, Hani; Taube, Eliane T.; Dorigo, Oliver; Horst, David; Keunecke, Carlotta; Baum, Joanna; Angelotti, Timothy; Sehouli, Jalid und Braicu, Elena Ioana
(2022):
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
In: Annals of Surgical Oncology, Bd. 30, Nr. 1: S. 35-45
Ruscito, Ilary; Castillo-Tong, Dan Cacsire; Vergote, Ignace; Ignat, Iulia; Stanske, Mandy; Vanderstichele, Adriaan; Glajzer, Jacek; Kulbe, Hagen; Trillsch, Fabian; Mustea, Alexander; Kreuzinger, Caroline; Panici, Pierluigi Benedetti; Gourley, Charlie; Gabra, Hani; Nuti, Marianna; Taube, Eliane T.; Kessler, Mirjana; Sehouli, Jalid; Darb-Esfahani, Silvia und Braicu, Elena Ioana
(2018):
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
In: British Journal of Cancer, Bd. 119, Nr. 3: S. 330-338
Ruscito, Ilary; Castillo-Tong, Dan Cacsire; Vergote, Ignace; Ignat, Iulia; Stanske, Mandy; Vanderstichele, Adriaan; Ganapathi, Ram N.; Glajzer, Jacek; Kulbe, Hagen; Trillsch, Fabian; Mustea, Alexander; Kreuzinger, Caroline; Panici, Pierluigi Benedetti; Gourley, Charlie; Gabra, Hani; Kessler, Mirjana; Sehouli, Jalid; Darb-Esfahani, Silvia und Braicu, Elena Ioana
(2017):
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
In: European Journal of Cancer, Bd. 79: S. 214-225